Effect of Dapagliflozin on Alanine Aminotransferase Improvement in Type 2 Diabetes Mellitus with Non-alcoholic Fatty Liver Disease

BACKGROUND: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are expected to improve the liver function of patients with non-alcoholic fatty liver disease (NAFLD) combined type 2 diabetes mellitus (T2DM) by its characteristic mechanism. This study was designed to investigate the effect of dapaglif...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Endocrinol Metab (Seoul)
Autors principals: Choi, Dug-Hyun, Jung, Chan-Hee, Mok, Ji-Oh, Kim, Chul-Hee, Kang, Sung-Koo, Kim, Bo-Yeon
Format: Artigo
Idioma:Inglês
Publicat: Korean Endocrine Society 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6145967/
https://ncbi.nlm.nih.gov/pubmed/30229578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2018.33.3.387
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars